| Opioid makers paid millions to advocacy groups: U.S. Senate report | | | (Reuters) - Five opioid manufacturers including OxyContin maker Purdue Pharma LP have paid more than $10 million to advocacy groups and doctors tied to them, many of whom amplified industry messages supporting the use of the painkillers, a U.S. Senate report said on Monday. |
| |
| U.S. woman found with eye worm previously known only in cattle | | | NEW YORK (Reuters) - An Oregon woman has become the first person worldwide known to have had an eye infestation by a tiny worm species previously seen only in cattle that is spread by flies that feed on eyeball lubrication, U.S. government researchers said on Monday. |
| |
| Novartis gains U.S. approval for delayed MS drug | | | ZURICH (Reuters) - Novartis's Sandoz division has won U.S. approval for a larger dosage of its Glatopa drug for multiple sclerosis (MS) patients, ending a costly delay that allowed rival generics makers to beat it to market. |
| |
| India cuts stent prices by more than 7 percent | | | NEW DELHI (Reuters) - India has cut prices of some stents by about 7.6 percent, a government body said on Monday, in the latest setback for the country's $5 billion medical device industry. |
| |
| OxyContin maker stops promoting opioids, cuts sales staff | | | (Reuters) - OxyContin maker Purdue Pharma LP said on Saturday that it has cut its sales force in half and will stop promoting opioids to physicians, following widespread criticism of the ways that drugmakers market addictive painkillers. |
| |
| | |
